HomeProductsBioactive CompoundsDNA Damage & RepairDNA-PKCanfosfamide
Chemical structure of CAS 158382-37-7

Canfosfamide

CAS No.158382-37-7
MDL No.N/A
MFC26H40Cl4N5O10PS
MW787.50
InChI KeyOJLHWPALWODJPQ-QNWVGRARSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Canfosfamide is an oligopeptide.

CAS No.158382-37-7
Product NameCanfosfamide

Associated Conditions

fallopian tube cancer·lung cancer·peritoneum cancer·breast neoplasm·ovarian cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society • Vol. 15, Issue 4 • 2005
PMID: 16014111DOI: 10.1111/j.1525-1438.2005.00114.x

Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 10, Issue 11 • 2004
PMID: 15173075DOI: 10.1158/1078-0432.CCR-03-0687

Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 9, Issue 5 • 2003
PMID: 12738715

Documentation